Epidemiology and microbiologic characterization of nosocomial candidemia from a Brazilian national surveillance program

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Doi, André Mario ^a   Pignatari, Antonio Carlos Campos ^a   Edmond, Michael B ^c   Marra, Alexandre Rodrigues ^b   Camargo, Luis Fernando Aranha ^b   Siqueira, Ricardo Andreotti ^a   Da Mota, Vivian Pereira ^a   Colombo, Arnaldo Lopes ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL RESISTANCE; BRAZIL; CANDIDA; CANDIDEMIA; CROSS INFECTION; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PREVALENCE; RISK FACTOR; SEX DIFFERENCE; SURVIVAL RATE;

BRAZIL; CANDIDA; CANDIDEMIA; CROSS INFECTION; DRUG RESISTANCE, FUNGAL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; SEX FACTORS; SURVIVAL RATE;

EID: 84978706859     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0146909     Document Type: Article

References (31)

1. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Meis JF, Gould IM, et al. Global Antifungal Surveillance Study. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol. 2007; 45(6): 1735-45.
2. Colombo AL, Guimarães T, Sukienik T, Pasqualotto AC, Andreotti R, Queiroz-Telles F, et al. Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter centers sequentially conducted over a 9-year Period. M. Intensive Care Med. 2014; 40(10): 1489-98
3. Ahmed A, Azim A, Baronia AK, Marak KRSK, Gurjar M. Risk prediction for invasive candidiasis. Indian J Crit Care Med. 2014; 18(10): 682-688.
4. Delaloye J, Calandra T. Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence. 2014; 5(1):161-9. doi: 10.4161/viru.26187 PMID: 24157707
5. Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, et al. Emerging infections program healthcare-associated infections and antimicrobial use prevalence survey team. 2014 Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 370(13):1198-208. doi: 10.1056/NEJMoa1306801 PMID: 24670166
6. Lortholary O, Renaudat C, Sitbon K, Madec Y, Denoeud-Ndam L, Wolff M, et al. Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area, 2002-2010). Intensive Care Med. 2014; 40(9): 1303-12. doi: 10.1007/s00134-014-3408-3 PMID: 25097069
7. Bassetti M, Righi E, Ansaldi F, Merelli M, Trucchi C, De Pascale G, et al. A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med. 2014; 40(6):839-45. doi: 10.1007/s00134-014-3310-z PMID: 24807083
8. Nucci M, Queiroz-Telles F, Alvarado-Matute T, Tiraboschi IN, Cortes J, Zurita J, et al. Epidemiology of candidemia in Latin America: a laboratory-based survey. PLOS One 2013; 8(3):e59373. doi: 10.1371/journal.pone.0059373 PMID: 23527176
9. Chen PY, Chuang YC, Wang JT, Sheng WH, Yu CJ, Che CC, et al. Comparison of epidemiology and treatment outcome of patients with candidemia at a teaching hospital in Northern Taiwan, in 2002 and 2010. J Microbiol Immunol Infect. 2014; 47(2):95-103. doi: 10.1016/j.jmii.2012.08.025 PMID: 23063082
10. Wille MP, Guimarães T, Furtado GHC, Colombo AL. Historical trends in the epidemiology of candidemia: analysis of an 11-year period in a tertiary care hospital in Brazil. Mem Inst Oswaldo Cruz, Rio de Janeiro. 2013; 108(3): 288-292.
11. Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, da Matta DA, et al. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol. 2006; 44(8): 2816-23. PMID: 16891497
12. Colombo AL, Garnica M, Aranha Camargo LF, Da Cunha CA, Bandeira AC, Borghi D, et al. Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals. Med Mycol. 2013; 51(1):38-44. doi: 10.3109/13693786.2012.698024 PMID: 22762208
13. Nucci M, Queiroz-Telles F, Tobon AM, Restrepo A, Colombo AL. Epidemiology of opportunistic fungal infections in Latin America. Clin. Infect. Dis. 2010; 51: 561-570). doi: 10.1086/655683 PMID: 20658942
14. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis. 1997; 24:1122-1128. PMID: 9195068
15. Pfaller MA, Andes DR, Diekema DJ, Horn DL, Reboli AC, Rotstein C, et al. Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004-2008. 2014; PLOS ONE 9(7): e101510. doi: 10.1371/journal.pone.0101510 PMID: 24991967
16. Chowdhary A, Kumar VA, Sharma C, Prakash A, Agarwal K, Dinesh KR, et al. Multidrug-resistant endemic clonal strain of Candida auris in India. Eur J Clin Microbiol Infect Dis. 2014; 33:919-926. doi: 10.1007/s10096-013-2027-1 PMID: 24357342
17. Pfaller MA, Castanheira M, Messer SA, Moet GJ, Jones RN. Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009). Diagn Microbiol Infect Dis. 2010; 68(3):278-83. doi: 10.1016/j.diagmicrobio.2010.06.015 PMID: 20846808
18. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Monzon A, Buitrago MJ, Rodriguez-Tudela JL. Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds. Antimicrob Agents Chemother 2009; 53(1):2192-2195.
19. Pfaller MA, Moet GJ, Messer SA, Jones RN, Castanheira M. Geographic variations in species distribution and echinocandin and azole antifungal resistance rates among Candida bloodstream infection isolates: report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009). J. Clin. Microbiol. 2011; 49:396-399. doi: 10.1128/JCM.01398-10 PMID: 21068282
20. Arendrup MC, Perlin DS. Echinocandin resistance: an emerging clinical problem? Curr Opin Infect Dis. 2014; 27(6): 484-92. doi: 10.1097/QCO.0000000000000111 PMID: 25304391
21. Souza AC, Fuchs BB, Pinhati HM, Siqueira RA, Hagen F, Meis JF, et al. Candida parapsilosis Resistance to fluconazole: molecular mechanisms and in vitro impact in infected Galleria mellonella larvae. Antimicrob Agents Chemother. 2015; 59(10):6581-7. doi: 10.1128/AAC.01177-15 PMID: 26259795
22. Castanheira M, Messer SA, Jones RN, Farrell DJ, Pfaller MA. Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections. Int J Antimicrob Agents. 2014; 44(4):320-6.
23. Bizerra FC, Jimenez-Ortigosa C, Souza ACR, Breda GL, Queiroz-Telles F, Perlin DS, et al. Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin. Antimicrob. Agents Chemother. 2014; 58(4):2438-40. doi: 10.1128/AAC.02189-13 PMID: 24468776
24. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard 3rd ed. CLSI document M27-A3. 2008; Clinical and Laboratory Standards Institute, Wayne, PA.
25. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; fourth informational supplement. CLSI document M27-S4. 2012; Clinical and Laboratory Standards Institute, Wayne, PA.
26. Marra AR, Camargo LFA, Pignatari ACC, Sukiennik T, Behar PRP, Medeiros EAS, et al. Nosocomial Bloodstream Infections in Brazilian Hospitals: Analysis of 2,563 Cases from a Prospective Nationwide Surveillance Study. J Clin Microbiol. 2011; 49(5): 1866-1871. doi: 10.1128/JCM.00376-11 PMID: 21411591
27. Brito LR, Guimaraes T, Nucci M, Rosas RC, Paula Almeida L, Da Matta DA, et al. Clinical and microbiological aspects of candidemia due to Candida parapsilosis in Brazilian tertiary care hospitals. Med Mycol. 2006; 44:261-266. PMID: 16702106
28. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study. Clin Infect Dis. 2004; 39(3): 309-317. PMID: 15306996
29. Kullberg BJ, Arendrup MC. Invasive Candidiasis. N Engl J Med. 2015; 373;15
30. Wisplinghoff H, Ebbers J, Geurtz L, Stefanik D, Major Y, Edmond MB, et al. Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Int J Antimicrob Agents 2014; 43:78-81. doi: 10.1016/j.ijantimicag.2013.09.005 PMID: 24182454
31. Nucci M, Thompson-Moya LO, Guzman-Blanco M, Tiraboschi IN, Cortes JA, Echevarria J, et al. Recommendations for the management of candidemia in adults in Latin America. Latin America Mycosis Network. Rev Iberoam Micol. 2013; 30(3):179-88.